Francesca Ceccherini Silberstein - JoVE Visualize

Showing results (91-100 of 254) with videos related to

Pageof 26

Sort By:

Microbiology Spectrum|March 30, 2022

Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational ProfileMohammad Alkhatib, Romina Salpini, Luca Carioti, et al.

Journal of Viral Hepatitis|February 18, 2021

The impact of DAA-mediated HCV eradication on CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation CohortAlessandra Bandera, Patrizia Lorenzini, Lucia Taramasso, et al.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2024

Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options-the ICONA Foundation cohort studySergio Lo Caputo, Mariacristina Poliseno, Alessandro Tavelli, et al.

Journal of Virological Methods|April 15, 2017

HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assayFrancescoPaolo Antonucci, Valeria Cento, Maria Chiara Sorbo, et al.

Viruses|August 28, 2021

SHARED: An International Collaboration to Unravel Hepatitis C ResistanceAnita Y M Howe, Francesca Ceccherini-Silberstein, Julia Dietz, et al.

Microorganisms|April 30, 2021

An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological SuppressionGiuseppina Brancaccio, Romina Salpini, Lorenzo Piermatteo, et al.

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 14, 2017

Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learningLize Cuypers, Pieter Libin, Yoeri Schrooten, et al.

The Journal of Infectious Diseases|October 24, 2007

Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patientsFrancesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.

The Journal of Antimicrobial Chemotherapy|November 30, 2020

Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune controlRomina Salpini, Mohammad Alkhatib, Giosuè Costa, et al.

Viruses|August 10, 2021

Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot StudyRossana Scutari, Valentino Costabile, Laura Galli, et al.

Pageof 26

Showing results (91-100 of 254) with videos related to

Sort By:

Pageof 26

Microbiology Spectrum|March 30, 2022

Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational ProfileMohammad Alkhatib, Romina Salpini, Luca Carioti, et al.

Journal of Viral Hepatitis|February 18, 2021

The impact of DAA-mediated HCV eradication on CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation CohortAlessandra Bandera, Patrizia Lorenzini, Lucia Taramasso, et al.

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2024

Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options-the ICONA Foundation cohort studySergio Lo Caputo, Mariacristina Poliseno, Alessandro Tavelli, et al.

Journal of Virological Methods|April 15, 2017

HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assayFrancescoPaolo Antonucci, Valeria Cento, Maria Chiara Sorbo, et al.

Viruses|August 28, 2021

SHARED: An International Collaboration to Unravel Hepatitis C ResistanceAnita Y M Howe, Francesca Ceccherini-Silberstein, Julia Dietz, et al.

Microorganisms|April 30, 2021

An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological SuppressionGiuseppina Brancaccio, Romina Salpini, Lorenzo Piermatteo, et al.

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 14, 2017

Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learningLize Cuypers, Pieter Libin, Yoeri Schrooten, et al.

The Journal of Infectious Diseases|October 24, 2007

Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patientsFrancesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.

The Journal of Antimicrobial Chemotherapy|November 30, 2020

Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune controlRomina Salpini, Mohammad Alkhatib, Giosuè Costa, et al.

Viruses|August 10, 2021

Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot StudyRossana Scutari, Valentino Costabile, Laura Galli, et al.

Pageof 26